iRhythm makes a wearable heart monitor and cloud analytics software used by physicians to diagnose arrhythmias. IRTC reports earnings on Thu, Nov 5, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). In the past 30 days there were 1 dark pool print.
Prices, price targets and earnings estimates for IRTC are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRTC is in one of them and how their past IRTC trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About iRhythm Holdings
iRhythm makes a wearable heart monitor and the cloud software that analyzes its data. The company also provides ambulatory cardiac monitoring services that help physicians diagnose irregular heartbeats. The small patch sticks to the chest and records heart activity over an extended period while patients go about daily life. Physicians and their patients are the main users, and the company is based in San Francisco, California.
